BETTER THERAPEUTICS, INC.

Analyst Reco. Better Therapeutics, Inc.

Equities

BTTX

US08773T1043

Market Closed - OTC Markets Other stock markets 03:53:14 2024-04-26 pm EDT			5-day change	1st Jan Change
0.01 ^USD	+11.11%		+63.93%	-94.87%

Mar. 21	Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc	CI
Mar. 20	Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lake Street Adjusts Better Therapeutics' Price Target to $5 From $6, Keeps Buy Rating	23-04-14	MT
Chardan Lowers Price Target on Better Therapeutics to $9 From $14, Reflecting Higher Projected Sharecount Dilution, Maintains Buy Rating	23-03-31	MT
Chardan Cuts Price Target on Better Therapeutics to $14 From $17 on Higher Expected Share Count Dilution, Reiterates Buy Rating	22-11-15	MT
Chardan Adjusts Better Therapeutics' Price Target to $17 From $15, Keeps Buy Rating	22-07-29	MT
Chardan Raises Price Target on Better Therapeutics to $18 From $17, Maintains Buy Rating	22-03-16	MT
LifeSci Capital Starts Better Therapeutics at Outperform With $15 Price Target	21-12-28	MT
Chardan Starts Better Therapeutics at Buy With $17 Price Target	21-11-24	MT
Cowen Initiates Coverage on Better Therapeutics With Outperform Rating	21-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer